[go: up one dir, main page]

FI921877L - Farmaceutiska foereningar - Google Patents

Farmaceutiska foereningar Download PDF

Info

Publication number
FI921877L
FI921877L FI921877A FI921877A FI921877L FI 921877 L FI921877 L FI 921877L FI 921877 A FI921877 A FI 921877A FI 921877 A FI921877 A FI 921877A FI 921877 L FI921877 L FI 921877L
Authority
FI
Finland
Prior art keywords
pharmaceutical associations
associations
pharmaceutical
Prior art date
Application number
FI921877A
Other languages
English (en)
Other versions
FI101795B1 (fi
FI921877A0 (fi
FI101795B (fi
Inventor
James Michael Greene
Holly Marie Hankins
Gregory Alan Stephenson
David Dale Wirth
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI921877A0 publication Critical patent/FI921877A0/fi
Publication of FI921877L publication Critical patent/FI921877L/fi
Application granted granted Critical
Publication of FI101795B1 publication Critical patent/FI101795B1/fi
Publication of FI101795B publication Critical patent/FI101795B/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Formation And Processing Of Food Products (AREA)
FI921877A 1991-04-29 1992-04-27 Menetelmiä diritromysiinin muodon II valmistamiseksi ja eristämiseksi sekä välituotteena käyttökelpoinen kiteinen diritromysiinin solvaatti FI101795B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69284291A 1991-04-29 1991-04-29
US69284291 1991-04-29

Publications (4)

Publication Number Publication Date
FI921877A0 FI921877A0 (fi) 1992-04-27
FI921877L true FI921877L (fi) 1992-10-30
FI101795B1 FI101795B1 (fi) 1998-08-31
FI101795B FI101795B (fi) 1998-08-31

Family

ID=24782254

Family Applications (2)

Application Number Title Priority Date Filing Date
FI921876A FI921876L (fi) 1991-04-29 1992-04-27 Farmaceutisk komposition innehaollande diritromycin
FI921877A FI101795B (fi) 1991-04-29 1992-04-27 Menetelmiä diritromysiinin muodon II valmistamiseksi ja eristämiseksi sekä välituotteena käyttökelpoinen kiteinen diritromysiinin solvaatti

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI921876A FI921876L (fi) 1991-04-29 1992-04-27 Farmaceutisk komposition innehaollande diritromycin

Country Status (27)

Country Link
EP (2) EP0511800B1 (fi)
JP (2) JP3333545B2 (fi)
KR (2) KR100194307B1 (fi)
CN (2) CN1069197C (fi)
AT (2) ATE138924T1 (fi)
AU (2) AU655978B2 (fi)
BR (2) BR9201540A (fi)
CA (2) CA2067274C (fi)
CY (2) CY1946A (fi)
CZ (2) CZ282021B6 (fi)
DE (2) DE69214710T2 (fi)
DK (2) DK0511800T3 (fi)
ES (2) ES2093779T3 (fi)
FI (2) FI921876L (fi)
GR (2) GR3020439T3 (fi)
HK (2) HK153696A (fi)
HU (2) HU215917B (fi)
IE (2) IE74885B1 (fi)
IL (2) IL101705A (fi)
MX (2) MX9201944A (fi)
MY (2) MY109498A (fi)
NO (2) NO180450C (fi)
NZ (2) NZ242505A (fi)
RU (2) RU2045953C1 (fi)
TW (2) TW315371B (fi)
YU (2) YU44492A (fi)
ZA (2) ZA922777B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW271400B (fi) * 1992-07-30 1996-03-01 Pfizer
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
IL127833A (en) * 1996-07-29 2004-06-20 Abbott Lab Preparation of the crystalline form II of clarithromycin
WO1998013027A1 (en) * 1996-09-24 1998-04-02 Eli Lilly And Company Coated particle formulation
US6390690B1 (en) 2000-05-17 2002-05-21 3M Innovative Properties Company Fiber optic connector for coupling devices on intersecting planes
NZ576719A (en) * 2006-12-05 2012-01-12 Pfizer Motilide polymorphs
CN102145008B (zh) * 2010-12-29 2013-06-05 辰欣药业股份有限公司 一种地红霉素药物组合物及其制备方法
CN107151261B (zh) * 2017-06-09 2020-06-12 广州大光制药有限公司 一种地红霉素化合物的晶型及其结晶制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2515075C2 (de) * 1975-04-07 1985-10-24 Dr. Karl Thomae Gmbh, 7950 Biberach Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
EP0184921A3 (en) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycin derivatives
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
DE69214710T2 (de) 1997-03-13
IE76296B1 (en) 1997-10-08
HU9203168D0 (en) 1992-12-28
RU2045953C1 (ru) 1995-10-20
DK0511800T3 (da) 1997-04-21
IL101705A0 (en) 1992-12-30
KR920019365A (ko) 1992-11-19
NO921616D0 (no) 1992-04-27
HUT62595A (en) 1993-05-28
CA2067275C (en) 2002-11-26
ATE138924T1 (de) 1996-06-15
NZ242505A (en) 1993-06-25
DE69211220T2 (de) 1996-11-07
HK153696A (en) 1996-08-16
BR9201541A (pt) 1992-12-01
YU44492A (sh) 1994-06-24
NO921616L (no) 1992-10-30
EP0511800A1 (en) 1992-11-04
NO179504C (no) 1996-10-23
IL101705A (en) 1996-01-31
CY1946A (en) 1992-04-27
TW315371B (fi) 1997-09-11
DK0511799T3 (da) 1996-06-24
HUT63956A (en) 1993-11-29
JPH05117289A (ja) 1993-05-14
AU646734B2 (en) 1994-03-03
FI921876L (fi) 1992-10-30
CN1066186A (zh) 1992-11-18
KR920019364A (ko) 1992-11-19
CS127792A3 (en) 1992-11-18
CN1069197C (zh) 2001-08-08
NO921617D0 (no) 1992-04-27
CY1975A (en) 1997-09-05
CN1030611C (zh) 1996-01-03
IE74885B1 (en) 1997-08-13
GR3020439T3 (en) 1996-10-31
TW216399B (fi) 1993-11-21
NO921617L (no) 1992-10-30
EP0511799B1 (en) 1996-06-05
GR3021706T3 (en) 1997-02-28
ES2093779T3 (es) 1997-01-01
CZ282218B6 (cs) 1997-06-11
DE69214710D1 (de) 1996-11-28
BR9201540A (pt) 1992-12-01
FI101795B1 (fi) 1998-08-31
KR100193742B1 (ko) 1999-06-15
JPH05117154A (ja) 1993-05-14
MY109498A (en) 1997-02-28
AU1525792A (en) 1992-11-05
CN1066270A (zh) 1992-11-18
CZ282021B6 (cs) 1997-04-16
EP0511799A1 (en) 1992-11-04
FI921877A0 (fi) 1992-04-27
CA2067275A1 (en) 1992-10-30
HU213613B (en) 1997-08-28
CS127692A3 (en) 1992-11-18
HU9201398D0 (en) 1992-07-28
RU2070203C1 (ru) 1996-12-10
AU655978B2 (en) 1995-01-19
JP3135672B2 (ja) 2001-02-19
AU1525592A (en) 1992-11-05
IE921346A1 (en) 1992-11-04
JP3333545B2 (ja) 2002-10-15
HU215917B (hu) 1999-03-29
DE69211220D1 (de) 1996-07-11
EP0511800B1 (en) 1996-10-23
ATE144425T1 (de) 1996-11-15
NO179504B (no) 1996-07-15
CA2067274C (en) 2002-10-15
ES2088098T3 (es) 1996-08-01
NZ242506A (en) 1993-09-27
NO180450C (no) 1997-04-23
FI101795B (fi) 1998-08-31
KR100194307B1 (ko) 1999-06-15
MY114226A (en) 2002-09-30
IL101704A (en) 1998-02-22
MX9201944A (es) 1992-11-01
HK215096A (en) 1996-12-13
ZA922776B (en) 1993-10-15
IL101704A0 (en) 1992-12-30
MX9201946A (es) 1992-11-01
YU44392A (sh) 1994-12-28
ZA922777B (en) 1993-10-15
IE921345A1 (en) 1992-11-04
NO180450B (no) 1997-01-13
FI921876A0 (fi) 1992-04-27
CA2067274A1 (en) 1992-10-30

Similar Documents

Publication Publication Date Title
FI911986L (fi) Farmaceutiska foereningar.
DK0616523T3 (da) Lægemidler
FI932445L (fi) Farmaceutiska foereningar
DK0515312T3 (da) Farmaceutisk præparat
EE03108B1 (et) Farmatseutiline kompositsioon
FI922252L (fi) Farmaceutisk sammansaettning
NO923127D0 (no) Farmasoeytisk kombinasjonsformulering
FI924340L (fi) Farmaceutiska beredningar
FI921060A0 (fi) Farmaceutiska aerosolformuleringar.
DK0585252T3 (da) Farmaceutiske formuleringer
NO923859D0 (no) Medikament
FI930882A (fi) Farmaceutiska foereningar
FI934194L (fi) Kontrastmedel
MX9200622A (es) Composicion farmaceutica
FI935065L (fi) Farmaceutiska foereningar
FI931251L (fi) Farmaceutiska foereningar
FI921877L (fi) Farmaceutiska foereningar
DK0511991T3 (da) Farmaceutisk formulering
FI921786A (fi) Farmaceutisk foerening
FI921785A (fi) Farmaceutisk foerening
FI923869L (fi) Farmaceutiska aemnen
DK75791D0 (da) Novel pharmaceutical preparations
NO920564D0 (no) Farmasoeytiske adenosinholdige preparater
SE9103213D0 (sv) Farmaceutisk komposition
SE9101348D0 (sv) Pharmaceutical composition